Roman Perri, M.D., medical director of the Liver Transplant program at Vanderbilt University Medical Center, has been named the Tennessee Hepatologist of the Year by the American Liver Foundation (ALF).

One of the most formidable weapons in a cancer’s arsenal is the ability to spread to other organs.

Robert Coffey Jr., M.D., Ingram Professor of Cancer Research at Vanderbilt University, has received a five-year, $5.2 million grant from the National Institutes of Health (NIH) to study the role of extracellular RNA (ex-RNA) in colorectal cancer.

A noninvasive test can be used to identify the presence of Helicobacter pylori and evaluate its virulence, which will be useful in areas with high rates of H. pylori-associated gastric cancer.

The American Gastroentero-logical Association (AGA) has honored Pelayo Correa, M.D., with its Distinguished Achievement Award, which recognizes an individual for contributions to research that have advanced the science and practice of gastroenterology.

Researchers at Vanderbilt University Medical Center led by a 32-year-old postdoctoral fellow have discovered a new mechanism for the development of cancer that is challenging conventional scientific wisdom.

The role of inflammation in gastrointestinal cancer development was a prominent theme among guest speakers during the Vanderbilt-Ingram Cancer Center annual retreat held at the Vanderbilt Student Life Center.